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Background: Despite the success of highly active antiretroviral therapy (HAART), HIV infected individuals remain at
increased risk for frailty and declines in physical function that are more often observed in older uninfected
individuals. This may reflect premature or accelerated muscle aging.
Methods: Skeletal muscle gene expression profiles were evaluated in three uninfected independent microarray
datasets including young (19 to 29 years old), middle aged (40 to 45 years old) and older (65 to 85 years old)
subjects, and a muscle dataset from HIV infected subjects (36 to 51 years old). Using Bayesian analysis, a ten gene
muscle aging signature was identified that distinguished young from old uninfected muscle and included the
senescence and cell cycle arrest gene p21/Cip1 (CDKN1A). This ten gene signature was then evaluated in muscle
specimens from a cohort of middle aged (30 to 55 years old) HIV infected individuals. Expression of p21/Cip1 and
related pathways were validated and further analyzed in a rodent model for HIV infection.
Results: We identify and replicate the expression of a set of muscle aging genes that were prematurely expressed
in HIV infected, but not uninfected, middle aged subjects. We validated select genes in a rodent model of chronic
HIV infection. Because the signature included p21/Cip1, a cell cycle arrest gene previously associated with muscle
aging and fibrosis, we explored pathways related to senescence and fibrosis. In addition to p21/Cip1, we observed
HIV associated upregulation of the senescence factor p16INK4a (CDKN2A) and fibrosis associated TGFβ1, CTGF,
COL1A1 and COL1A2. Fibrosis in muscle tissue was quantified based on collagen deposition and confirmed to be
elevated in association with infection status. Fiber type composition was also measured and displayed a significant
increase in slow twitch fibers associated with infection.
Conclusions: The expression of genes associated with a muscle aging signature is prematurely upregulated in HIV
infection, with a prominent role for fibrotic pathways. Based on these data, therapeutic interventions that promote
muscle function and attenuate pro-fibrotic gene expression should be considered in future studies.
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Despite the considerable success of highly active anti-
retroviral therapy (HAART), individuals chronically
infected with HIV remain at higher risk for declines in
musculoskeletal function and increased frailty [1-3], a
phenotype also observed in rodent models for HIV in-
fection [4,5]. In humans, this functional decline resem-
bles an aging phenotype, since many of these risk factors* Correspondence: mmontano@bu.edu
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reproduction in any medium, provided the orare more often seen in the elderly. However, the molecu-
lar and regulatory pathways that underlie this process re-
main vaguely defined.
Studies on muscle aging in both humans and rodent
models have shown increases in collagen deposition and
fibrotic tissue in aging muscle [6-10], suggesting a skew-
ing in the balance of muscle and fibroblasts with in-
creasing age. Transforming growth factor β (TGFβ) is a
known key regulator in maintaining the balance of colla-
gen in the extracellular matrix as well as in modulating
inflammatory responses [11,12] . It is normally expressed
in muscle after injury but also has the potential totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Injection of TGFβ for ten days has been shown to in-
duce cachexia and generalized tissue fibrosis in nude
mice [14]. Furthermore, Carlson and colleagues have
shown an upregulation of TGFβ and associated path-
ways in muscle in the aging rodent [15]. Based on these
observations of muscle aging in model systems and a
similar frailty phenotype in rodent models for infection,
we were interested in determining whether premature
muscle aging occurs during chronic HIV infection, par-
ticularly in the context of successful HAART and
whether this phenotype is recapitulated in rodent mod-
els for HIV.
To evaluate potential muscle aging within the context
of HIV infection, we chose to first evaluate gene expres-
sion of muscle specimens (that is, vastus lateralis) in un-
infected individuals ranging in age from 19 to 85 using
previously published datasets for healthy aging and mild
sarcopenia to identify an aging gene signature [16,17].
To assess the possibility of accelerated muscle aging in
HIV, we then evaluated muscle gene expression profiles
in HIV-infected individuals ranging in age from 30 to
55 years old and in a rodent model for HIV infection
and used this to identify associated pathways that might
explain the phenotype seen. Senescence, a hallmark of
aging, has been defined as an irreversible state of cell
cycle arrest [18]. In this study, genes and pathways
related to muscle senescence and fibrosis were found to
be upregulated and were evaluated further. Here, we de-
scribe a role for HIV driven fibrosis in skeletal muscle.
This is an understudied potential mediator of functional




These studies were approved by the Boston University
Medical Center Institutional Review Board, and the
McMaster University and Hamilton Health Sciences Re-
search Ethics Board. These studies were conducted in
accordance with the principles of the Declaration of Hel-




This study included HIV-positive men, 30 to 55 years
old (average age = 43 years), who had documented
weight loss within the previous six months of between
5% and 15% of body weight or an actual body mass
index (BMI) at screening of between 17 and 20 (equiva-
lent to 85% to 95% of the lower limit of ideal weight), an
energy intake in excess of 80% of the recommended diet-
ary allowance, on stable and potent antiretroviraltherapy for at least 12 weeks or not starting antiretro-
viral therapy in the next four months, CD4 cell count
greater than 50/mm3 and HIV copy number less than
10,000 copies/ml (less than 400 in six of nine subjects),
and were able and willing to provide informed consent
and comply with the protocol. Expression profiles were
from biopsies of the vastus lateralis at baseline that were
not previously published in a testosterone supplementa-
tion study [19]. Arrays were run using Affymetrix HG-
U133A microarray chips.
GEO datasets
The online datasets GEO362 [20] and GEO 1428 [16]
are expression profiles of muscle tissue from normal
human muscle biopsies of the vastus lateralis. GEO362
arrayed young men (age 21 to 27) and older men (age 67
to 75). GSE 1428 looked at young men (age 19 to 25)
and older men (age 70 to 80) who were identified as
having mild sarcopenia. The de-identified data were
downloaded from the Gene Expression Omnibus (GEO)
web repository and were used in our analysis. Arrays for
both these studies were run using Affymetrix HG-
U133A microarray chips.
Supplemental healthy HIV negative dataset
These subjects were enrolled at McMaster University
and Hamilton Health Sciences and were all healthy non-
exercising males. None were athletes nor were they on
medications known to adversely affect muscle (that is,
statins). The age intervals for these subjects were 20 to
25 years old, 40 to 45 years old, and 70 to 75 years old.
Muscle biopsies of the vastus lateralis were taken at the
same time of day and fasted, as previously described [21]




All expression data were globally scaled to a per sample
mean of 500. Probes were assigned to be present or ab-
sent based on the per sample median. Probes with more
than 80% absent calls were removed from GSE1428 and
GSE362. Only probes in GSE362 and GSE1428 with at
least one sample intensity above the median for each re-
spective set were considered for analysis using Bayesian
Analysis of Differentially Expressed Genes (BADGE)
[22]. As a result, a total of 9,872 probes from GSE362
and 11,016 probes from GSE1428 were included in our
analysis. Remaining probes were analyzed for differential
expression using BADGE [22].
Differential expression
The GSE362 and GSE1428 data sets were analyzed in-
dependently. Our analysis found 26 upregulated and
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pression in the arrays being compared) for GSE362
and 19 upregulated and 65 downregulated genes for
GSE1428 using a 0.5% posterior probability of false
positive detection. Ten genes overlapped between the
two analyses.
Specificity assessment
To assess whether the ten gene muscle aging signature
reflected a generic muscle disease phenotype, we evalu-
ated our ten gene signature in several other muscle
aging diseases such as myositis, amyotrophic lateral
sclerosis (ALS), and 48 hour immobilization using PEPR
(Public Expression Profile Resource; http://pepr.cnmcre-
search.org). Our profile was only significant in 48 hour
immobilization, and not any of the other diseases stud-
ied (data not shown). To test whether the ten gene
muscle aging profile in HIV samples clustered selectively
with the expression profiles of older subjects’ muscles,
we used a Bayesian model based cluster analysis of the
ten genes. The cluster method was implemented in the
software CAGED (Cluster Analysis of Gene Expression
Dynamics) which was also used to generate the unsuper-
vised clustered heatmaps [23].
EASE annotation
Annotation of our gene lists was performed using the
National Center for Biotechnology Information (NCBI)
software EASE [24]. EASE is an integrated knowledge
database that integrates information from OMIM,
Refseq, Unigene, and Gene Ontology to search for over-
represented gene categories in user submitted gene lists
[25].
Ex vivo validation and pathway analysis
TGFβ protein measurement
Muscle homogenates were obtained from the gastrocne-
mius muscle of the wild type and HIV Tg rodent. Briefly,
samples were cleaned of all fat and connective tissue and
cut into smaller pieces. Specimens were homogenized in
RIPA buffer (25 mM Tris pH7.6, 150 mM NaCl, 1% NP-
40, 1% sodium deoxycholate, 0.1% SDS) with complete
mini protease inhibitor tablets added (Roche, IN, USA).
Homogenates were centrifuged at 21,000 g for 15 min-
utes to pellet insoluble matter. Protein concentrations
were determined using the BCA reagent (Pierce, Rock-
ford IL, USA). TGFβ was measured by ELISA using a
Quantikine kit (R&D Systems, Minneapolis, MN, USA)
according to the manufacturer’s recommendations and
values were normalized to total protein concentration.
Three HIV Tg and three wild type rodents were used for
these measurements. A Students t-test of the data was
used to test differential expression with a P-value< 0.05
considered as significant.RNA quantitative realtime PCR
RNA was generated from gastrocnemius muscles. Briefly,
the gastrocnemius muscles were cleaned of all fat and ex-
cess connective tissue, cut into smaller pieces and homo-
genized in TRIzol reagent (Invitrogen, Carlsbad, CA,
USA}) then processed for RNA. Phase separation was
done using chloroform and centrifugation. RNA was pre-
cipitated from the aqueous phase using isopropynol and
washed using ethanol. The RNA was then cleaned using
the RNeasy Mini Kit (Qiagen Sciences, Valencia, CA,
USA) and quantified using a Nanodrop spectrophotom-
eter. Primers for rat GAPDH, CDKN1A, FEZ2 and H3F3B
were purchased from Superarray (SABiosciences, Fred-
erick, MD, USA) and analyzed using quantitative realtime
PCR detection with SYBR green. For genes associated
with fibrosis, COL1A1 (F-GGAATGAAGGGACACA-
GAGGT, R- GAGCTCCATTTTCACCAGGA), COL1A2
(F-GAGCTCCATTTTCACCAGGA, R- CAGCAGCTC-
CACTCTCACCT), CTGF (F-ATGCTGTGAGGAGTGG-
GTGT, R- GGCCAAATGTGTCTTCCAGT) and GAPDH
(F- ATGACTCTACCCACGGCAAG, R- GGAAGATGGT-
GATGGGTTTC), primers were used - a kind gift from Dr.
Maria Trojanowska (Boston University, MA). They were
analyzed using quantitative realtime PCR detection using
SYBR green. TaqMan probes for rat p16INK4a, MT1A,
MLF1, TPPP3 (also known as CGI-38), MYH8, PDHA1
and GAPDH were purchased from Applied Biosystems
(Life Technologies, Carlsbad, CA, USA). Both sets were
analyzed using an ABI Prism 7000 Sequence Detection Sys-
tem (Applied Biosystems, Life Technologies, CA, USA).
Samples were confirmed to have no DNA contamination
by using a realtime PCR reaction without reverse transcript-
ase. Amplification results were normalized to GAPDH
using the ΔΔCt method. A Students t-test of the data was
used to test differential expression with a P-value< 0.05
considered as significant.
Collagen staining and fibrotic index calculation
Gastrocnemius muscle was flash frozen in liquid nitro-
gen and later embedded in paraffin. Sections of tissue
were processed at 5 μm thickness. Tissue was stained
using Picrosirius Red (Sigma-Aldrich, St. Louis, MO,
USA}) and Fast Green (Fisher Scientific, Hampton, NH,
USA) to look for collagen deposition in the extracellular
space. The images for analysis of fibrotic index were
taken using Olympus BX41 microscope (Olympus, Cen-
ter Valley, PA, USA) using DP Controller (Version
3.2.1.276) and DP Manager (Version 3,1,1,208). Bright
field images were exposed for 1/1500 seconds. The fi-
brotic index was calculated as percent area of collagen
of the total tissue area using NIH Image J Software
(http://rsbweb.nih.gov/ij/). The calculation for fibrotic
index is based on the algorithm described in [26]. Six
HIV Tg and three wild type rodent muscles were
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was used to test differential expression with a P-value<
0.05 considered as significant.
Myosin heavy chain isoform quantification
Gastrocnemius muscles were embedded in OCT and im-
mediately frozen in isopentane cooled in liquid nitrogen.
Serial sections from the mid-belly of the gastrocnemius
were cut at 8 μm and processed for immunohistochem-
ical detection of slow or fast MHC protein expression
using the ABC method (Vector Labs, Burlingame, CA,
USA). Sections were visualized with a Leica microscope
and measured using ImageJ software (NIH, Bethesda,
MD, USA). Approximately 200 fibers per muscle were
analyzed. Data are expressed as the percentage of slow
(type I) and fast (type II) MHC types relative to the total
pool of MHC isoforms. Four HIV Tg and four wild type
rodent muscles were quantified. A Students t-test was
used to test differential expression with a P-value of less
than 0.05 considered as significant.
Results and discussion
Identification of common genes that change expression
with muscle aging
To profile muscle in healthy aging, we identified a
shared gene expression pattern in healthy and mildly
sarcopenic individuals using previously published ex-
pression data obtained from the same tissue and micro-
array platform (that is, Affymetrix HG-U133A). We then
evaluated this expression pattern with microarray data
from our HIV muscle specimens using the same micro-
array platform (that is, Affymetrix HG-U133A) as well
as with a distinct microarray dataset of young, middle
aged and older men using a NimbleGen platform
(Table 1). A Bayesian modeling approach was applied,
implemented in BADGE [22,23], using muscle expres-
sion datasets obtained from the vastus lateralis in GEO
series 362 (a dataset including seven young healthy men
ages 21 to 27 and eight older men ages 67 to 75 [20])
and GEO series 1428 (a dataset including ten young
healthy men ages 19 to 25 and twelve older men with
mild sarcopenia ages 70 to 80 [16]). The initial analysis
identified 62 age-associated probes that were differen-
tially expressed in the dataset GSE362 and 85 age-asso-
ciated probes differentially expressed in the datasetTable 1 Description of datasets used in this study
Dataset Age(yrs) Sample Size(all male) Tissue s
GSE362 [20] 21-2767-75 N= 7N= 8 Vastus la
GSE1428 [16] 19-2570-80 N= 10N= 12 Vastus la
HIV + [19] 36-51 N= 9 Vastus la
Supplemental Healthy 20-2540–4570-75 N= 10N= 10N= 10 Vastus laGSE1428. Ten genes were common to both expression
sets and are shown for the two datasets as heatmaps in
Figures 1A and B. Notably the mild sarcopenia in the
GEO 1428 series displayed a larger number of differen-
tially expressed genes compared to healthy subjects (data
not shown). This ten gene signature was evaluated in an-
other supplemental healthy male dataset run on a Nim-
bleGen microarray platform, comparing subjects 20 to
25 years old with subjects 70 to 75 years old. Most genes
(the top six of ten in the heatmap) in the signature were
recapitulated in the third set (Figure 1C). The compos-
ition of the ten genes shown in all three datasets is as
follows: CDKN1A (p21/Cip1), FEZ2, H3F3B DAAM2,
MFL1, PDHA1 MT1F, MYH8, CRIM1, and CGI-38.
The GSE362 and GSE1428 genome-wide expression
data have been previously published and are available
online [16,20]. The HIV baseline muscle profiles and the
supplemental healthy muscle expression profiles have
not been previously published. Cells/CMM=cells per
cubic milliliter.
Muscle gene expression of middle-aged HIV-infected men
resembles older uninfected samples
Using the muscle aging profile common to both data-
sets, we evaluated muscle expression profiles from HIV-
infected individuals using the same tissue source (vastus
lateralis) and microarray platform (Affymetrix HG-
U133A). The samples are described in [19]. Muscle pro-
files from these subjects clustered with the older samples
in both GSE362 (shown in Figure 2A) and GSE1428
(data not shown) using CAGED [23] cluster analysis.
Notably, the clustering was not influenced by viral load,
extent of weight loss or CD4 levels (data not shown).
Collectively, these data suggest that muscle derived from
HIV+men, on average in their 40s, more closely resem-
bles muscle profiles from individuals in their 70s consist-
ent with our premise of accelerated muscle aging.
Muscle gene expression of age-matched healthy HIV
negative men do not resemble older samples
We evaluated muscle profiles from young, middle aged
and older uninfected men, all derived using the same tis-
sue site and microarray platform (Table 1), to determine
whether age, rather than HIV, might account for the
observed clustering in Figure 2A. However, CAGEDource Array Condition
teralis HG-U133A Healthy
teralis HG-U133A Older with sarcopenia
teralis HG-U133A Median VL = 400 copies/ML
(400–56,844)Median CD4= 362 cells/CMM (61–765)
teralis NimbleGen Healthy
Figure 1 Muscle age profiling. Heatmaps displaying the relative expression of the ten gene muscle aging profile are shown comparing young
males to older males in a supervised manner using Affymetrix U133A microarray gene set data for GSE362 (A) and GSE1428 (B) and in a healthy
aging dataset using a NimbleGen microarray data (C). The gene expression of the profile is displayed in a supervised manner where intensity
reflects relative expression (green= higher, red = lower). Heatmaps were generated using the Heatplus package in the statistical software R 2.14.0.
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aged men clustering randomly with the young group
and the old group, see Figure 2B. Notably, when middle
aged healthy men were removed from the analysis, we
again observed clear partitioning of the young from the
old (Figure 1C), confirming that young and old in this
dataset also recapitulate the ten gene muscle signature,
as observed in Figure 1 A and B. These data areFigure 2 A. Muscle age profiling with HIV. Heatmap displaying the ten
GSE1428 (Figure 2A) and GSE362 (similar results, data not shown). The CAG
map) based on the ten gene muscle aging profile (columns of the heat m
samples (designated by arrows and in bold, 36 to 51 years old) cluster with
cluster analysis uses a model-based procedure that assigns samples to the
model. Numbers attached to the branches of the dendrogram represent th
model that does not. B. CAGED analysis of the expression of the ten gene
25 years old), intermediate (40 to 45 years old designated by arrows), and
microarray NimbleGen platform). The gene expression of the profile is disp
expression (green= higher than average, red = lower than average). CAGEDconsistent with the possibility that HIV infection pro-
motes premature expression of this gene signature in
muscle.
Expression of the aging signature in a transgenic rodent
model for chronic HIV infection
One of the genes in our signature, the cyclin dependent
kinase inhibitor (CDKi) p21/Cip1, has been associatedgene profile shown in Figure 1, with the HIV group added using
ED software was used to cluster samples (shown as rows of the heat
ap). The analysis shows that the young men form a cluster, while HIV
old subjects using the ten gene muscle aging profile. The CAGED
same cluster if their merging increases the posterior probability of the
e posterior odds of the model that merges the branches versus the
muscle aging profile is an HIV negative dataset with young (20 to
old (70 to 75 years old) subjects (this entire dataset used the
layed in a supervised manner where intensity reflects relative
, Cluster Analysis of Gene Expression Dynamics.
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were, therefore, interested in whether a transgenic ro-
dent model for HIV infection (HIV Tg) would display
premature elevation of p21/Cip1 expression as well as
the other genes in our signature. The HIV Tg rodent
expresses a transgene consisting of a HIV provirus with
a functional deletion of pol and gag regulated by the viral
long terminal repeat. These rodents share many similar-
ities to human HIV infection, compared to other rodent
models. Specifically, these rodents express the virus in
lymph nodes, spleen, kidney, thymus and immune cells
including macrophages, T cells and B cells, are antigenic
to gp120 and shed gp120 into the peripheral blood
stream and have immune suppression compared to wild
type animals. Furthermore, by five to nine months of
age, these animals develop weight loss, neurological ab-
normalities, respiratory difficulties and other symptoms
of AIDS [27,28]. We chose to use the HIV Tg rodent
model for chronic infection because this model displays
musculoskeletal decline that includes loss in lean
muscle and resorption of bone, both phenotypes
observed in human HIV infection [4,5]. As shown in
Figure 3A, we observed significant up-regulated expres-
sion of p21/Cip1, as well as most of the other aging sig-
nature genes or gene homologues (for example, Fez2,Figure 3 Expression of p21/Cip1, p16INK4a and TGFβ1 in the HIV tran
p21/Cip1, Fez2, H3, MFL1, MT1F and MYH8 in muscle from HIV transgenic g
and shows an increase in genes in HIV Tg compared to age matched wild
indicating the standard deviation. The difference between wild type and H
cycle arrest gene, p16INK4a, in HIV Tg rat (n =4) compared to wild type (n
mean fold change with the error bars indicative of the standard deviation.
HIV transgenic gastrocnemius muscle (n = 3) or wild type gastrocnemius m
significance of P< 0.05. Bar plots indicate mean protein levels with error ba
factor β.H3F3b(H3), CGI-38, MT1, MYH8) using quantitative
real time PCR analysis in concordance with expression
in the microarray profiles observed in our human
muscle specimens. CRIM1 was found to show a trend
increase with the HIV Tg compared to the wild type but
did not show statistical significance (P = 0.08). Notably,
three genes, PDHA, DAAM2 and MLF1 were not sig-
nificantly different between the wild type and HIV
transgenic rat (data not shown), possibly indicating spe-
cies-specific regulation.
p16INK4a is upregulated in a transgenic rodent model for
chronic HIV infection
Recent data have linked elevated p21/Cip1 to other cell
cycle arrest genes such as p16INK4a, with healthy aging
in muscle stem cells [15] and other tissue specific stem
cells [29,30]. To assess whether cell cycle arrest was a
general feature in the muscle in our rodent model, we
measured p16INK4a RNA levels in both the HIV Tg and
wild type rodent. Figure 3B shows that the levels of
p16INK4a were significantly elevated compared with
wild type age-matched controls. This further suggests
that cell cycle arrest genes are prematurely expressed in
muscle during HIV infection, specifically that both the
Cip and Ink4 families are induced.sgenic rodent. A. Realtime RNA PCR validation was observed for
astrocnemius (n = 4) muscle or wild type gastrocnemius muscle (n = 3)
type controls. All bar plots show mean fold change with error bars
IV Tg is significant to P≤ 0.05. B. RT-PCR shows an increase in the cell
= 3). The difference is significant to P< 0.05. The bar plot indicates
C. TGFβ1 protein levels based on ELISA of muscle homogenates from
uscle (n = 3) show increased levels in the HIV Tg rodent at a
rs indicative of the standard deviation. TGFβ, transforming growth
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chronic HIV infection
The TGFβ family members, including TGFβ itself, as
well as the growth antagonist myostatin, have been
shown to upregulate p21/Cip1 and p16INK4a in aging
muscle in both the stem cell population and the muscle
fibers in mice [6,15]. Expression of both p21/Cip1 and
p16INK4a has also been shown to be upregulated in a
number of human aging studies in leukocytes, fibro-
blasts, neural tissue and pancreatic islet cells [18,29-39].
This upregulation of p16INK4a is thought to be asso-
ciated with aging and senescence. To evaluate whether
TGFβ protein might also be upregulated in our HIV
muscle in addition to the senescence-associated genes,
we measured protein levels in muscle homogenates from
HIV Tg and age-matched wild type rodents at the onset
of bone and muscle loss (approximately seven months of
age). As shown in Figure 3C, we observed a dramatic in-
crease in TGFβ protein levels in HIV Tg animals com-
pared to wild type controls, consistent with elevated
TGFβ in muscle aging studies in rodents [15].
The collagen gene inducer, CTGF, as well as collagen
gene expression are induced in a transgenic rodent
model for chronic HIV infection
Elevated TGFβ levels have been previously linked to de-
position of collagen and tissue fibrosis of lymph nodes
in both human HIV infection and in simian immuno-
deficiency virus (SIV) models of infection [40,41]. Fur-
thermore, in aging, muscle from rodents has been
shown to convert to a fibrogenic phenotype [6]. How-
ever, fibrotic genes and collagen deposition in skeletal
muscle have not yet been described in the context of
HIV infection. We, therefore, measured genes associatedFigure 4 Expression of collagen genes in the HIV transgenic rodent m
HIV Tg rat muscle (n = 3) compared to wild type (n = 3) using realtime RNA
change with error bars indicative of standard deviation. B. The collagen ge
compared to wild type (n = 3) using realtime RNA PCR. The bar plots indica
deviation. The difference between wild type and HIV Tg rodents are signifiwith TGFβ and collagen deposition in the hindlimb
muscle (gastrocnemius) of the wild type and HIV Tg ro-
dent. We first examined the collagen transcriptional in-
ducer, connective tissue growth factor (CTGF), a factor
that mediates TGFβ induced collagen gene expression
[42,43]. As shown in Figure 4A, there was an increase in
expression in CTGF in the HIV Tg rodents. We then
measured the expression of collagen genes, COL1A1
and COL1A2. As shown in Figure 4B, these genes were
also upregulated in the HIV Tg rodent.
The HIV tg rodent muscle exhibits fibrosis and fiber type
switching in muscle
Because we saw evidence of the upregulation of collagen
genes in HIV, to evaluate whether collagen deposition was
detectable in association with upregulated TGFβ and col-
lagen genes, we analyzed gastrocnemius tissue sections
and quantified collagen content. As shown in Figure 5,
there was a significant increase in muscle collagen depos-
ition in the HIV Tg rodent compared to the wild type con-
trols. This is consistent with aging muscle, which also
shows an increase in collagen deposition [6]. Since aging
is also associated with a shift in fiber types, specifically an
increase in slow twitch and a decrease in fast twitch [44-
46], we analyzed the types of fibers seen in the gastrocne-
mius in the wild type compared to the HIV Tg. We found
that as with aging, there is a significant increase in slow
twitch fibers and decrease in the fast twitch fibers in the
HIV Tg rat compared to the wild type.
Conclusions
With the success of anti-retroviral therapy in suppressing
viral burden there has been a profound influence on the
course of HIV infection from a lethal to a managedodel. A. The collagen transcriptional regulator, CTGF, is increased in
PCR at a significance of P <0.05. The bar plots indicate mean fold
nes, COL1A1 and COL1A2 are increase in HIV Tg rat muscle (n =3)
te mean fold change with the error bars indicative of standard
cant to P< 0.05. CTGF, connective tissue growth factor.
Figure 5 Collagen deposition and fiber type switching in the HIV transgenic rat. Histological muscle sections of the gastrocnemius muscle
of HIV Tg (n = 6) and control wild type rats (n = 3) were stained using Picrosirius Red for collagen. Representative images are shown in A and B.
The scale bar equals 200 μm. A. Tissue section of the gastrocnemius muscle in wild type rat shows collagen deposition in red in intracellular
space. B. Tissue section of gastrocnemius muscle from HIV Tg rat shows increased collagen deposition in red in the intracellular spaces. C.
Quantification of the area of picrosirius red staining using Image J shows that there is an increase in fibrotic index in the HIV Tg rat compared to
the wild type at a significance of P< 0.05. The bar plot indicates mean percent area of collagen with the error bars indicative of the standard
deviation. D. Quantification of fiber type was done using Image J on control wild type (n = 4) and HIV Tg (n = 4). The bar plot indicates the
percentage of fibers of each type with error bars indicative of standard deviation.
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main at higher than expected risk for a number of compli-
cations typically associated with aging [47]. Aging is often
defined on the basis of functional capacity, or frailty, ra-
ther than the collection of age-associated diseases [48,49].
Frailty, as defined in the elderly by Fried and colleagues,
[50] has been previously evaluated in men with HIV [1,2]
wherein a significant frailty-related phenotype (FRP) has
been observed. Margolick and colleagues have also
reported the premature occurrence of age-adjusted frailty
with HIV infection [1-3].
With the advancing age of the HIV-infected popula-
tion, the role of aging-associated inflammation in com-
promising normal tissue remodeling is becoming
increasingly more relevant. In 2006, approximately one
third of people with AIDS in the US were over age 50
[49]. Chronic inflammation that occurs with increasing
age has been shown to adversely affect muscle homeo-
stasis [51-53], with aging muscle increasingly likely to
exhibit changes in extracellular matrix resembling a
fibrogenic phenotype [6-9]. Recently, SIV infection has
been linked with fibroblast deposition of collagen and
increased fibrosis in lymph nodes associated with an in-
crease in local TGFβ production [40,54,55]. However, adetailed study of fibrosis in skeletal muscle in chronic
HIV infection has not been done to date. In this study,
we use an aging signature in muscle to identify and
evaluate aging- and fibrosis-related pathways in the ro-
dent model of HIV. We show gene expression changes
and phenotypic changes in muscle in an HIV Tg rodent
model similar to that seen in aging. We see an upregula-
tion of genes associated with aging muscle prematurely
expressed in HIV in both the human and the rat. We,
furthermore, show changes in both fiber type compos-
ition and in fibrotic collagen deposition in the HIV ro-
dent. Previous work by our laboratory in humans has
also shown that an increase in CTGF expression in vas-
tus lateralis from HIV-positive men was downregulated
with anabolic supplementation in microarray analysis
(see supplemental data in [19]), consistent with our find-
ings of a dysregulation of CTGF in HIV. Collectively
these data suggest that the genotypic and phenotypic
changes that we see might be related to HIV infection.
This data also elucidate pathways HIV might use that re-
sult in increased risk for a frailty-related phenotype.
Three independent datasets were used in this study to
identify an aging gene signature that differs between
older individuals and younger individuals. This signature
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aging profile genes include: CDKN1A/p21, FEZ2,
H3F3B, DAAM2, MLF1, PDHA1, MT1F, MYH8 and
CRIM1. FEZ2 is a factor that interacts with a number of
transcription controlling proteins to influence chromatin
remodeling and apoptosis [56]. H3F3B is a replacement
histone that constitutes the major form of histone H3 in
senescent cells [57]. DAAM2 regulates cell fate and
actin-cytoskeleton re-organization through WNT signal-
ing [58]. Previous studies have shown that changes in
actin cytoskeleton turnover can trigger an increase in
levels of reactive oxygen species (ROS) in the cytosol
and, therefore, decrease cellular viability [59]. MLF1
suppresses COP1 through COP9 thereby stabilizing p53
[60]. PDHA1 is a mitochondrial metabolic enzyme that
provides the link between glycolysis and the TCA cycle
[61]. MT1F and MT1A have a metalloregulatory function
in repair, growth, and differentiation [62] with MT1A being
a similar family methallothionein to MT1F in the rat.
MYH8 is a member of the myosin protein family and is
involved in muscle contraction by interacting with actin
filaments [63]. CRIM1 is a membrane bound protein that is
known to interact with the TGFβ superfamily [64].
CDKN1A (p21/Cip1) is a well-recognized cell cyclin
dependent kinase inhibitor that has been associated with
muscle aging and cellular senescence that has not been pre-
viously linked with muscle aging in HIV infection. Whether
these genes reflect a larger network of regulators in aging
that are co-opted in HIV is beyond the scope of this study
and will require further network and pathway analysis of
these genes and their potential interactions during healthy
and dysregulated muscle aging. It is of note that while these
genes displayed a robust signature in our two initial data-
sets, GSE363 and GSE 1428, the signature did not fully re-
capitulate in a third cohort (shown in Figure 1C).
Furthermore, the genes that erode in the heatmap for the
third cohort include PDHA, MLF1 and DAAM2 and are
the same genes that did not show significant changes in the
HIV Tg rat model compared to the wild type (data not
shown). This data suggest that these three genes may not
remain as robust as the others and will require further ana-
lysis of additional independent datasets.
In this study, we see selected senescence-ssociated path-
ways in addition to the fibrosis pathways prematurely
expressed in HIV infection. Based on these results, we
propose that HIV infection may represent an uncoupled
and dysregulated aging phenotype that increases the risk
for muscle fibrosis. Senescence-associated pathways have
been previously implicated in muscle aging, but have not
been directly linked to HIV infection. Recent studies on
senescence and aging indicate that cellular senescence is
accompanied by a striking increase in the secretion of 40
to 80 factors [34,38,65,66], termed the ‘senescence-asso-
ciated secretory phenotype’ or SASP [35], an ensemble offactors that includes multiple inflammatory cytokines.
Previous studies on senescence show that the cells respon-
sible for the release of SASP factors show an upregulation
in key senescence-associated genes including p21 and
p16INK4a [35-37,39,65]. In muscle, these genes are
thought to contribute to a decreased regenerative capacity
with aging that has been seen in rodents as they have been
detected in both fibers and satellite cells [15,53]. We show
the premature upregulation of p21/Cip1 in both human
and rodent muscle tissue with HIV and the premature
upregulation of p16INK4a in rodent muscle tissue sug-
gesting that a senescence axis might be activated early
with HIV infection. What cell types in the muscle (that is,
satellite cells, fibroblast or mature muscle cells) contribute
to the changes in gene expression is beyond the scope of
this study and will require further analysis. Furthermore,
whether or not the upregulation of these genes contri-
butes to a dysregulation of the satellite cells in HIV
muscle leading to an aging phenotype is an intriguing area
of future study.
As previously mentioned, many of the factors that in-
crease in serum with aging include inflammatory cyto-
kines including TGFβ, TNFα and IL-6 [34-36,38,39,67-
69]. Some of these circulating factors have been shown
to dampen proliferation of satellite cells, lead to remod-
eling of the stem cell niche and lead to dysregulation of
stem cell function specifically in muscle [15,53,70]. HIV
is also associated with an increase in systemic inflamma-
tory burden, especially in serum factors like IL-6
[1,2,69,71,72]. Increases in systemic inflammatory cyto-
kines are also known to lead to a loss of muscle mass
[73-78]. Whether the gene signature that we see in HIV
and aging is due to a common increase in inflammatory
burden or whether HIV infection itself drives both the
signature and inflammatory process is an intriguing
question that remains beyond the scope of this study.
In addition to inflammation, previous studies dissect-
ing acute conditions leading to muscle atrophy have
revealed a common role for the ubiquitin proteasome
pathway mediated by the E3 ligases MuRF1 and MAFBx
to promote muscle protein degradation, notably the
muscle structural protein myosin heavy chain [79-82].
Upstream activators for these atrogenes include FOXO
and NFκB pathways [83] and have been identified in
multiple rodent models of induced wasting, notably can-
cer-associated cachexia [84] and also HIV in a rodent
model for infection [5]. While we do not see an upregu-
lation of atrogenes in our genetic signature in aging, the
HIV transgenic rodent model has previously been shown
to have an increase in MuRF1 compared to the wild type
[4]. Therefore, the atrogene pathway may represent an-
other pathway in addition to the fibrotic and senescence
pathways we study that shows dysregulation from the
normal aging pattern seen specifically in HIV.
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area that has been understudied with the etiology poorly
understood. Further evaluation of both the senescent and
fibrotic pathways and genes in association with muscle
function in healthy aging and in HIV infection should bet-
ter assist in identifying molecular pathways associated with
frailty in both conditions. Increased frailty is likely to cre-
ate a substantial burden on future health care, underscor-
ing a need for diagnostic biomarkers and early detection in
this population. The role of chronic inflammation driven
fibrosis in HIV is an understudied potential mediator of
functional decline. Further characterization of this pheno-
type could open avenues for therapeutic intervention to
prevent fibrosis associated declines in physical function.
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